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Differential scanning calorimetryTo better understand the relationship between the relative cytotoxicity of diluted ionic liquids and their speciﬁc
interaction with biological membranes, the thermotropic behavior of model lipid membrane systems for-
mulated in a series of choline based organic salts was investigated. Unilamellar vesicles prepared from
dipalmitoylphosphatidylcholine were exposed to a series of choline phosphate salts at a concentration of
10 mMat pH 7.40, and the gel to liquid-crystalline state transitionwas examined using differential scanning cal-
orimetry. The choline salts thatwere observed to have a low relative toxicity in previous studies inducedminimal
changes in the lipid phase transition behavior of these model membranes. In contrast, the salts choline
bis(2,4,4-trimethylpentyl)phosphinate and choline bis(2-ethylhexyl)phosphate, both of which were observed
to have high relative toxicity, caused distinct disruptions in the lipid phase transition behavior, consistent with
penetration of the salts into the acyl chains of the phospholipids. choline bis(2,4,4-trimethylpentyl)phosphinate
reduced the Tm and enthalpy of the main transition of dipalmitoylphosphatidylcholine while choline
bis(2-ethylhexyl)phosphate induced the equilibration of alternate phases.
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Low melting point organic salts (Tm b 100 °C), frequently re-
ferred to as ionic liquids (ILs), have recently been explored as
solvents/co-solvents for a variety of biotechnology applications,
ranging from the formulation of biopharmaceuticals to media for
biocatalysis [1–3]. In some cases these ILs are being studied as pure
solvents, with little to no water present, and in other applications
they are studied in composition with water, sometimes with water
as the dominant co-solvent [1,2,4,5]. The growing potential for ILs
in this arena raises questions as to how ILs behave in the human
body and/or in ecosystems. The disposition of ILs in the environment
or in the human body will be largely dictated by the behavior of the
organic ions after they have been diluted into a predominantly aque-
ous environment. To date, biological compatibility of ILs formulated
in aqueous media has generally been explored in the context of
high-throughput assays which study the relative toxicity of ILs towards
particular species or cell types [3,6–9]. While these types of assaysphate; CDBP, choline dibutyl
e; CDHP, choline dihydrogen
phinate; DPPC, 1,2-dipalmitoyl-
alorimetry; IL, ionic liquid
lable: chemical structures of
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l rights reserved.provide useful information as to how certain chemical structures affect
toxicity trends, the information does not elucidate the speciﬁc molecu-
lar interaction with cellular organelles, such as the cell membrane.
Much of what we currently know about the nature of IL interac-
tions with membranes originates from observations made from cyto-
toxicity studies. Alkylimidazolium salts have been most extensively
tested, revealing a direct link between alkyl side-chain length and
cell toxicity. It has been suggested that toxicity is linked to lipophilic-
ity, where hydrophobic side chains increase membrane permeability
and thus cause necrotic effects [8,10,11]. In previous cytotoxicity
studies with choline based ILs, our group observed that as alkyl
chain length and branching increased on the anionic component of
the IL, the cytotoxicity to mammalian cells increased [3]. This increase
in cytotoxicity was hypothesized to be related to an increase in lipo-
philicity, and thus more disruptive interactions with mammalian
cell membranes. It has also been shown by others that the adverse ef-
fects of anionic surfactants on viability and growth of different marine
microalgae species appear to be related to interaction between the
outer plasmatic-membrane of the cell with compounds available in
the environment [12]. Both electrostatic interactions at the membrane
surface and hydrophobic interactions with lipid acyl chains can inﬂuence
the penetration of hydrophobic compounds into the core of membranes
by altering lipid arrangement. The nature of these interactions can
cause physical perturbations of the membrane that lead to cell leak-
iness, and penetration of compounds across the membrane, thus en-
abling interactions with intra-cytoplasmic organelles.
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Fig. 1. Chemical structures of the ion components of the choline salts: choline dihydrogen phosphate (CDHP), choline dibutyl phosphate (CDBP), choline O,O′-diethyl dithiophosphate
(CDEP), choline bis(2,4,4-trimethylpentyl) phosphinate (CTMP), choline bis(2-ethylhexyl)phosphate (CBEH), and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC).
1 Correction of previously reported Tm = 119 °C. [4] K. Fujita, D.R. MacFarlane, M.
Forsyth, Protein solubilising and stabilising ionic liquids, Chemical communications
(Cambridge, England), (2005) 4804–4806.
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ILs and biological interfaces, we have investigated in this work the ef-
fect of certain choline based ILs and organic salts on the thermotropic
phase behavior of model lipid membrane systems prepared from
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (Fig. 1). Using
calorimetric methods we examined the heat signals associated with
the lamellar gel (Lβ) to lamellar liquid crystalline (Lα) phase transi-
tion of unilamellar vesicles prepared from DPPC. The temperature at
which this event occurs can be described as the melting temperature
(Tm) of the hydrocarbon chains. Because of the tight packing and
restricted mobility of hydrocarbon acyl chains in a bilayer arrange-
ment, this transition from the all-trans conformation to the gauche
conformation is a highly cooperative event [13]. Molecules that
interact or intercalate with the acyl chains can signiﬁcantly affect
the cooperativity of this transition. Thermal parameters that were
monitored to probe bilayer effects include the temperature at the
transition peak (Tm), the width of the transition peak at half height
(ΔT1/2), and the enthalpy of the transition change (ΔH) [14].
2. Materials and methods
2.1. Materials
Lyophilized lipid 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 16:0
(DPPC) was purchased from Avanti Polar Lipids (Alabaster, AL). Sodium
chloridewas obtained fromFisher Scientiﬁc (Pittsburgh, PA). Crystalline
sodium phosphate dibasic, 7-hydrate (Na2HPO4·7H2O) was purchased
from J. T. Baker (Phillipsburg, NJ). Bis(2,4,4-trimethylpentyl) phosphinic
acid was obtained from Cytec Industries (Woodland Park, NJ). Cholinechloride, choline hydroxide (20 wt.% in H2O), methanol, dibutyl
phosphate, bis(2-ethylhexyl) phosphate, O,O′-diethyl dithiophosphate,
nortriptyline hydrochloride, procainamide hydrochloride, ibuprofen
sodium salt, and 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic
acid (HEPES) were all purchased from Sigma Aldrich (St. Louis, MO).
All chemicals were used as received, except as otherwise speciﬁed.
ELGA Purelab Ultra water (18.2 MΩ.cm) was used in the preparation
of all water based solutions.
2.2. Synthesis of choline salts
Five choline salts were prepared at Monash University according
to previous methods:
(1) 2-hydroxyethyl(trimethyl)azanium dihydrogen phosphate
(CDHP, choline dihydrogen phosphate), melting point = 195 °C
[15],1
(2) 2-hydroxyethyl(trimethyl)azanium bis(2,4,4-trimethylpentyl)
phosphinate (CTMP, choline bis(2,4,4-trimethylpentyl)phos
phinate), melting point = 131.2 °C [3],
(3) 2-hydroxyethyl(trimethyl)azanium O,O′-diethyl dithiophosphate
(CDEP, choline O,O′-diethyl dithiophosphate), melting point =
−43.6 °C [3],
(4) 2-hydroxyethyl(trimethyl)azanium dibutyl phosphate (CDBP,
choline dibutyl phosphate), melting point = 79 °C [3,16]
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(CBEH, choline bis(2-ethylhexyl)phosphate). Melting point
is not well deﬁned, but there is a glass transition (onset
temperature) = −83.2 °C [3].
Melting points were determined using a TA Instruments Q100
differential scanning calorimeter (DSC) over a temperature range
of −100 to 200 °C at a scanning rate of 10 °C/min. CDHP and CTMP
are solids at room temperature, but with the addition of small
amounts of water [≤20% (w/w)] produce clear liquids. However,
they are considered as near-ILs since they are liquid at room temper-
ature when hydrated with 20% (w/w) H2O [17]. CDBP is a liquidous
salt (semi-crystalline) at room temperature. CDEP and CBEH are
viscous liquids at room temperature.
2.3. Preparation of unilamellar vesicles
To study model membranes, a mini-extruder was used as de-
scribed in the Avanti Polar Lipids, Inc. protocol for preparing large,
unilamellar vesicles by extrusion as found at http://Avantilipids.
com. In order to prepare unilamellar liposomal suspensions with a
low polydispersity, membranes having a pore size of ≤0.2 μm were
used as recommended. Stock lyophilized DPPC was stored under an
argon atmosphere in a−20 °C freezer until used. To prepare lipid so-
lutions, lyophilized DPPC powder was placed into disposable glass
culture tubes with two glass beads and 20 mM HEPES buffer at
pH 7.40, which had been pre-warmed to 70 °C using a isotemp
heating block (Fisher Scientiﬁc, Pittsburgh, PA). The lipid solutions
were then vortexed, and placed in the heating block at 70 °C
for 30 min with occasional agitation to allow complete hydration.
The lipid solutions were then extruded through Nucleopore® track-
etched polycarbonateﬁlters (pore size 100 nm) (Whatman, Pleasanton,
CA) mounted in a mini-extruder (Avanti Polar Lipids, Alabaster, AL)
ﬁtted with two 1.0 mLHamilton gas-tight syringes (Avanti Polar Lipids,
Alabaster, AL). In order to achieve a tighter polydispersity (particle size
distribution), the lipid solutions were subjected to 21 passes through
the two ﬁlters after which the lipid vesicle solutions were collected
from the receiving syringe to prevent contamination by particles that
had not passed through the ﬁlter. The extrusions were refrigerated at
4 °C for a minimum of 16 h before use in calorimetry experiments.
2.4. Differential scanning calorimetry (DSC)
A MicroCal VP-DSC microcalorimeter (MicroCal, Northampton,
MA) was used to assess the thermal stability of all samples. DSC base-
line repeatability was established with a minimum of 5 reference so-
lution scans. The DPPC dispersions were prepared and allowed to
equilibrate overnight (16 h) at 4–5 °C. The dispersions were not incu-
bated longer than overnight in order to limit the inducement of the
subgel phase which normally occurs within 4–5 days at 0–4 °C [18].
After the refrigerated incubation period, and just prior to loading
samples into the DSC, the lipid dispersions were gently allowed to
warm to room temperature. An aliquot of the stock lipid vesicle solu-
tion was combined with experimental compounds in 20 mM HEPES
buffer at pH 7.40 in a 1:1 ratio by volume where dilution resulted in
a 10 mM test compound experimental concentration in the calorime-
ter sample cell. The experimental test compound concentration of
10 mM was chosen to allow a comparison of membrane interactions
at a level where toxic and non-toxic interactions could be discrimi-
nated [3]. Enough stock lipid vesicle solution was prepared initially
to allow a control (lipid only) DSC run for each compound tested.
The test solutions were mixed in thermovac tubes (MicroCal,
Northampton, MA), and immediately degassed for 5 min using a
thermovac vacuum degassing system (MicroCal, Northampton, MA).
After degassing, the samples were loaded by syringe into the calorime-
ter. After loading into the calorimeter sample cell, the samples wereallowed to equilibrate 15 min at the initial starting temperature of ei-
ther 10 or 20 °C then scanned from 20 to 50 °C or from 10 to 90 °C at
60 °C/h with a 16 second ﬁlter and passive feedback (gain). Reversibil-
ity was determined by rescanning samples after allowing them to cool
down to initial temperature. The samples were repeatedly scanned
until at least three consistent thermograms were obtained consecu-
tively. The datawas analyzedusingOrigin software providedbyMicroCal
in order to permit the determination of the main transition temperature
(Tm), the main transition full-width-at-half-maximum-height (ΔT1/2),
and the calorimetric enthalpy (ΔH).
3. Results and discussion
In previous work we have shown that for a series of choline
salts signiﬁcant differences were observed in the biocompatibility of
these salts with a macrophage cell line over a 48 hour exposure
period. Mouse macrophage (J774) cells were exposed to choline
salts that were added to the growth medium which consisted of
Dulbecco's Modiﬁed Eagle's Medium (DMEM) with inorganic and
organic components at original concentrations and supplemented
with 4500 mg/L D-glucose and 110 mg/L sodium pyruvate [3]. These
chronic exposure studies enabled a rank ordering of salts based on
the concentration required to reduce survival to 50% after 48 h of ex-
posure (EC50). Some of the choline salts were as benign as typical
physiologic salts, causing injury only when the concentration reached
a level that would induce osmotic stress (CDHP, CDBP, and CDEP).
Other choline salts (CTMP and CBEH) reduced survival at much lower
concentrations. The apparent cellular toxicity appeared to trend with
the lipophilicity of the compound, andwe hypothesized that adverse in-
teractions with the lipid cell membrane were the source of this toxicity
[3]. The mammalian cell plasma membrane consists of a variety of
biomacromolecules, arranged into complex assemblies that are not
readily amenable to calorimetric study. The primary components are
proteins and lipids, and simple, single-component bilayer lipid vesicles
are often used as model systems for cells [19–21]. To better understand
the nature of lipid membrane interactions, model vesicles formed
from phospholipids were exposed to choline salts and other well-
characterized control compounds to elucidate perturbing effects on
the model membranes that might lead to leakiness or general loss of
membrane structure. DPPC was chosen as the vesicle forming lipid
due to the fact that the major fatty acid in the choline-containing class
of glycerophospholipids found in mouse macrophages is palmitic acid
(16:0) [22]. The DPPC model membrane being used in this DSC study
is thus intended to serve as the most basic mimic of the mouse macro-
phage cell membrane.
In order to identify the speciﬁc thermal signatures associated with
different types of interfacial interactions, control compounds with
well-known effects on cell membranes were added to DPPC vesicles,
and changes in the membrane transition behavior of the lipids were
evaluated using DSC (see supplementary information Fig. S1 for
structures of control compounds). DSC measures enthalpy changes
associated with a given phase change, and the endotherms for DPPC
vesicles in 20 mM HEPES at pH 7.40 without added control com-
pounds exhibited the characteristic thermotropic behavior, demon-
strating both a pretransition at 36 °C and a gel–liquid crystal phase
transition at 41.4 °C, in agreement with previous reports (Fig. 2A)
[23]. Mixtures of choline salts and DPPC vesicles were studied at sim-
ilar lipid concentrations (approximately 0.39 mM) under the same
experimental conditions to allow comparison of speciﬁc interactions
between the salts and the lipid vesicles. Simple physiological salts
were also included for comparison. In order to compare the thermo-
tropic behavior of DPPC in relation to each compound, the main transi-
tion temperature, the enthalpy change, and the level of cooperativity
(ΔT1/2) with respect to each compound were gathered for comparison
in Table 1, along with indications regarding pretransition effects.
Previously published EC50 (mM) values for the set of choline salts
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Fig. 2. Calorimetric curves for lipid bilayer mixtures. All solutions were prepared at pH = 7.40 in 20 mM HEPES. Panel A: Representative calorimetric curves for DPPC control in
20 mM HEPES (top), 10 mM CDEP (center) and 10 mM CTMP (bottom) lipid bilayer mixtures. Panel B: Representative calorimetric ﬁrst scan curves for 10 mM CBEH lipid bilayer
mixtures showing a dominate transition at 27.0 °C (top) and reduced main transitions (bottom). Panel C: DSC thermograms of DPPC liposomes in (a) in 20 mM HEPES main
transition Tm = 41.1 °C, (b) 0.1 mM CBEH, second scan, Tm = 40.6 °C, (c) 1.0 mM CBEH, second scan, main transition Tm = 36.4 °C, and (d) 10 mM CBEH, second scan, subgel
transition Tm = 20.0 °C.
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are ranked based on their relative cellular toxicity. Initial heating scans
were also compared with subsequent reheating scans of the same
sample.
3.1. Low toxicity salts
As shown in Table 1, CDHP, and CDBP had no statistically signiﬁ-
cant effect on the DPPC main gel to liquid-crystal phase transition
(ΔTm, ΔΔH) and minimal effect on the change in the width of the
transition at half-height (ΔΔT1/2) suggesting that there was no inter-
action between these salts and the acyl chains of the lipids at the
studied concentration. The most benign salts tested previously for
cytotoxicity were NaCl and choline chloride (CCl) with EC50s of 63
and 34 mM respectively (Table 1) [3]. The thermotropic behavior
of these two salts was comparable to the low toxicity cholinecompounds, as well as the control compound procainamide, all hav-
ing little to no effect on the main transition enthalpy and little effect
on Tm and cooperativity (ΔΔT1/2) compared to control DPPC
runs from the same lipid batch solutions (Table 1). Procainamide
has previously been classiﬁed as nonmembrane active towards
dimyristoylphosphatidylcholine (DMPC), and appears to have the
same effect on DPPC [21]. This suggests that the variation in toxic-
ity observed with these compounds (CDHP: EC50 = 20 mM) and
(CDBP: EC50 = 9 mM) when compared to more cellularly benign
NaCl (EC50 = 60 mM) might have more to do with an aspect of
cellular function, such as alteration of membrane proteins, ionic
strength effects, nutrient sequestration or metal chelation, and does
not appear to be due to lipid membrane localization (Table 1).
It was noted that the pretransition peak normally seen at approx-
imately 36 °C was not resolvable in the thermal scans of DPPC in
the presence of CDEP (EC50 = 8 mM) while the main transition
Table 1
Thermodynamic parameters of the phase transitions undergone by 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 16:0 PC (DPPC) in different liposome preparations.a
Sampleb,c Main transition Change in main transitiond Pretransition Change in pretransitiond EC50e
(mM)
Tm
(°C)
ΔH
(cal mol−1)
ΔT(1/2)
(°C)
ΔTm
(°C)
ΔΔH
(cal mol−1)
ΔΔT(1/2)
(°C)
ΔH
(cal mol−1)
ΔH
(cal mol−1)
Control compounds
Nortriptyline hydrochloride 30.66
(0.05)
8078
(78)
1.41
(0.04)
−26% +8% +6% NR −100% –
Procainamide hydrochloride 41.46
(0.01)
7892
(209)
1.44
(0.03)
+0.2% +0.3% −9% 173
(13)
−47% –
Ibuprofen sodium salt 38.82
(0.15)
7222
(170)
1.79
(0.04)
−6% −11% +12% 375
(47)
−13% –
Choline salts
CDHP 41.69
(0.01)
7949
(121)
1.33
(0.00)
+0.7% +3% −6% 248
(14)
−54% 20
CDBP 41.05
(0.13)
7831
(218)
1.50
(0.09)
−0.5% +2% −6% 440
(73)
−20% 9.1
CDEP 40.68
(0.02)
8102
(53)
1.71
(0.04)
−2% +2% +14% NR −100% 8.2
CBEH f 42.49
(1.21)
77
(>23)
2.95
(>0.90)
+2.5% −99% +16% 66
(>20)
−82% b0.30
CTMP g 32.58
(0.09)
3580
(11)
1.48
(0.00)
−21% −52% −17% NR −100% b0.25
Inorganic/high melting point organic salts
NaCl 41.72
(0.03)
9823
(134)
1.53
(0.06)
+0.8% +17% −4% 508
(38)
+103% 63
CCl 41.70
(0.02)
9633
(133)
1.55
(0.04)
+0.8% +15% −3% 378
(7)
+51% 34
a All samples were prepared in 20 mM HEPES buffer at pH 7.40. All compound concentrations are 10 mM. A control DPPC scan was obtained on the stock LUVs batch solutions as
prepared for all compounds tested. Triplicate testing was run for all compounds except where otherwise noted. Values reported are for equilibrium scans which were reproducible
after rescanning for a minimum of four scans unless otherwise noted. Not resolvable (NR) under these experimental conditions. The standard error is given in parenthesis.
b CDHP, choline dihydrogen phosphate; CTMP, choline bis(2,4,4-trimethylpentyl)phosphinate; CDEP, choline O,O′-diethyl dithiophosphate; CDBP, choline dibutyl phosphate; CBEH,
choline bis(2-ethylhexyl)phosphate; CCl, choline chloride; NaCl, sodium chloride.
c Grand average from all DPPC control runs combined: Main Transition Tm = 41.35 ± 0.05 °C, ΔH = 7892 ± 100 cal mol−1, ΔT1/2 = 1.62 ± 0.06 °C; Pretransition ΔH = 364 ±
26 cal mol−1, n = 14.
d Change in thermodynamic parameters induced by compound compared to DPPC control scan from same LUV batch solution.
e EC50 values reproduced fromWeaver et al. [3].
f The gel-to-liquid-crystalline transition is not reversible in the presence of 10 mMCBEH, i.e., there is not an observablemain transition after cooling and rescanning in the presence of
this compound. The resolution of the pretransition and main transition peaks is low, and there is a higher degree of error in the calculated enthalpies.
g Average values from two replicates.
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to liquid-crystal phase transition (Fig. 2A, Table 1). This might suggest
that CDEP is interacting with the surface of the lipid bilayer in a man-
ner similar to that of nortriptyline. With the addition of nortriptyline
to DPPC, the thermal transitions were shifted to lower temperatures,
with notable main peak broadening (ΔΔT1/2) indicating reduction in
the molecular ordering of lipid molecules within the vesicle bilayer
and reduction in the cooperativity of melting without altering the
overall domain organization to such an extent that overall enthalpy
was changed [20,21]. A previous confocal Raman spectroscopy inves-
tigation on the partitioning of nortriptyline into DPPC vesicles indi-
cated that this molecule is located in the lipid interfacial/headgroup
region with the cyclic rings of the structure associating near the
acyl chains with the polar carbon tail “snorkeling” into the lipid
headgroup [20,21]. Head group interactions of this nature can cause
a signiﬁcant depression in the transition temperature of the gel to
liquid-crystalline phase change [20]. In the case of CDEP this effect
appears to be moderate, but could account for the lower gel to
liquid-crystal phase transition and the slightly lower EC50 value com-
pared to CDHP and CDBP.
3.2. High toxicity salts
The organic salts CBEH and CTMPwere both observed to have a high
toxicity in previous studies. Their structures suggest that they would be
highly lipophilic, and thus likely to cause perturbations in membrane
structure that would affect lipid phase transitions. Changes in lipidtransition behavior were indeed observed, and indicate a certain level
of lipid interaction. The salt CTMP (Log EC50 = b2.39 μM) reduced the
main transition Tm to 32.6 °C compared to that for DPPC alone, reduced
the transition enthalpy by half, and increased the cooperativity of the
transition, as measured by a decrease in the peak width (ΔΔT1/2) by
17%, compared to control lipid vesicles run from the same stock batch
solution (Fig. 2A, Table 1). CTMP also reduced the pretransition peak
below resolvable limits. These changes are consistent with both acyl
chain interaction and head group interaction within the lipid mem-
brane. Intercalation of CTMP into the lipid membrane acyl chain region
would give a signature much like that of the control compound ibupro-
fen, i.e., a lower Tm and reduction in enthalpy. Typically, acyl chain
interactions are not associated with a change in the pretransition tem-
perature or enthalpy, but it is possible that the temperature associated
with the pretransition peak has been reduced as well, moving below
the range tested (20 to 50 °C). The branched structure of CTMP would
suggest that if the compound penetrated into the acyl chains, consider-
able disorder would be expected. It is possible that the acyl chain
disordering is so extensive that the headgroup region is altered as a
secondary effect, and not necessarily because of a direct surface interac-
tion with CTMP. This hypothesis would explain why the thermal signa-
ture displays characteristics of both strong acyl chain interactions
(depressed main transition and enthalpy), and molecular changes
around the head group (loss of the pretransition peak). Repeated
scans were consistent indicating that the lipid vesicles remained intact.
The salt CBEH, which has a branched alkyl chain anionic structure
and a Log EC50 value b2.47 μM, exhibited much more complex
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at a concentration of 10 mM. For each of the compounds investi-
gated, including the controls, thermal reversibility was tracked by
allowing the samples to cool back to the starting temperature fol-
lowing the initial heating scan and then reheating for at least 5
scans. With the exception of CBEH, for all of the compounds tested
at a concentration of 10 mM, the gel to liquid-crystal phase transi-
tion was reversible with less than a 5% reduction in enthalpy upon
reheating (data not shown). The initial heating scan of DPPC in the
presence of 10 mM CBEH underwent a reduced pretransition near
33 °C, and a reduced main transition near 41 °C, with a reduction
in enthalpy of 82 and 99%, respectively, compared to DPPC in
HEPES alone (Table 1, Fig. 2B). A third peak was observed at
27 °C which was much higher in enthalpy than that observed for
the peaks at either 33 or 41 °C making it difﬁcult to observe all
three peaks plotted to the same scale (Fig. 2B). That is, in the pres-
ence of 10 mM CBEH, DPPC underwent three phase transitions
with four possible lamellar phases observed across the ﬁrst temper-
ature scan when starting at 20 °C and heating to 50 °C where the
expected transitions at 33 and 41 °C were signiﬁcantly reduced. Fur-
ther, only the ﬁrst heating scan yielded these results. The second
through fourth reheating scans after cooling back to the initial tem-
perature resulted in a reversible but altered dispersion where the
phase transition ﬁrst observed at 27 °C was reduced, and there was
no resolvable main transition at 41 °C. It is possible that there was
a uniform population of vesicles that underwent all of these transi-
tions in the ﬁrst scan, but more likely there was a mixed population
of vesicles present with varying degrees of CBEH incorporation that
ultimately converged to a uniform population after repeated thermal
scanning.
To better understand the thermal signatures in the DPPC–CBEH
samples, additional preparations were scanned over a wider tem-
perature range from 10 to 90 °C (Fig. 2C). DPPC control samples
(without added organic salts) scanned across the same temperature
range changed little from those that were scanned from 20 to 50 °C,
where the predominant feature is the strong main transition ob-
served at 41 °C with a less pronounced pretransition at 36 °C
(Fig. 2C). When scanning DPPC–CBEH (10 mM) samples over the
larger temperature range a certain level of thermal annealing was
apparent as the rescans (scan 2 and up) exhibited a change in peak
distribution compared to the ﬁrst heating scan where a new transi-
tion occurred at 20 °C and the 27 °C transition was reduced (data
not shown). Others have reported a DPPC subgel crystalline bilayer
(Lc) phase transition at 20 °C followed by transition into the gel
phase at 27 °C depending on how the lipid was hydrated [24]. The
DPPC batch solution was incubated for the same temperature and
time period as all the other batch solutions, and there were no indi-
cations of the presence of annealing changes in the presence of any of
the other compounds.
Additional DSC runs were included for preparations of DPPC in the
presence of CBEH in concentrations lower than 10 mM in order to
determine if the differences in thermotropic behavior were concen-
tration dependent, as might be expected based on toxicity data.
As can be seen in Fig. 2C, the extent of disruption of the membrane,
as measured in this case by peak depression and broadening, was
found to be directly proportional to concentration. After passing
through an initial heating scan with a Tm = 40.64 ± 0.07 °C, ΔT1/2 =
2.12 ± 0.00 °C, reducing the CBEH concentration to 0.1 mM resulted
in a reversible main peak transition with a Tm = 40.61 ± 0.16 °C and
(ΔT1/2 = 1.68 ± 0.15 °C) (n = 3) (Fig. 2C). After passing through an
initial heating scan with a Tm = 36.81 ± 0.33 °C and ΔT1/2 = 1.59 ±
0.00 °C, reducing theCBEH concentration to 1.0 mMyielded a reversible
main peak transition with a Tm = 36.41 ± 0.41 °C and ΔT1/2 =2.26 ±
0.19 °C (n = 2) (Fig. 2C). All concentrations of CBEH investigated signif-
icantly reduced the presence of the pretransition peak at approximately
36 °C normally associated with DPPC lipid vesicle preparations.4. Conclusions
In the current study we investigated the interaction of a family of
choline salts, which had been previously evaluated for toxic cellular
interactions, with model membranes prepared from DPPC, a major
phospholipid in macrophage membranes. Our studies used calorimet-
ric methods to monitor changes in the gel to liquid-crystalline transi-
tion of DPPC, as this phase change is very sensitive to molecules that
interact with the membrane. We were able to establish that organic
salts with high toxicity proﬁles drastically altered the lipid phase
change behavior of model membranes. These studies revealed that
the phase transition behavior of a lipid membrane exposed to
choline-based organic salt solutions can be dramatically affected by
the structure of the anion. This has implications not only for designing
biocompatible salts, but also for any biotechnology application in
which membrane interaction is important.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2013.03.017.
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